학술논문
Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation
Document Type
Article
Author
Source
In Leukemia Research October 2018 73:78-85
Subject
Language
ISSN
0145-2126